Briggs Morrison - 24 May 2024 Form 4 Insider Report for Werewolf Therapeutics, Inc. (HOWL)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HOWL	Stock Option (right to buy)	Award	$0	+17,500		$0.000000	17,500	24 May 2024	Common Stock	17,500	$4.88	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option was granted on May 24, 2024. The shares underlying the option vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders following the grant date, subject to the reporting person's continued service as a director.